(Q33383179)

26 July 2017

Association of genetic polymorphisms with interferon-induced haematologic adverse effects in chronic hepatitis C patients (English)

1 reference

26 July 2017

1 reference

1 reference

R Yamada

3

0 references

Masatoshi Kudo

object named as

M Kudo

6

0 references

author name string

M Wada

1

1 reference

26 July 2017

H Marusawa

2

1 reference

26 July 2017

A Nasu

4

1 reference

26 July 2017

Y Osaki

5

1 reference

26 July 2017

M Nabeshima

7

1 reference

26 July 2017

Y Fukuda

8

1 reference

26 July 2017

T Chiba

9

1 reference

26 July 2017

F Matsuda

10

1 reference

26 July 2017

5 February 2009

1 reference

Journal of Viral Hepatitis

26 July 2017

9

1 reference

based on heuristic

inferred from page(s)

published in

1 reference

26 July 2017

16

1 reference

26 July 2017

388-396

1 reference

26 July 2017

6

1 reference

National institutes of health consensus development conference statement: Management of hepatitis C: 2002 — June 10–12, 2002

26 July 2017

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.2009.01095.X

Crossref

reference URL

Peginterferon-alpha2a and ribavirin combination therapy in chronic hepatitis C: a randomized study of treatment duration and ribavirin dose

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.2009.01095.X

Crossref

reference URL

Pathogenesis, natural history, treatment, and prevention of hepatitis C.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.2009.01095.X

Crossref

reference URL

10.1111/J.1365-2893.2009.01095.X

21 January 2018

Identifiers

DOI

1 reference

26 July 2017

1 reference